Literature DB >> 27662009

Innate lymphoid cells are expanded and functionally altered in chronic lymphocytic leukemia.

Iris de Weerdt1,2, Vera van Hoeven1, J Marius Munneke1, Sanne Endstra1,2, Tom Hofland1,2, Mette D Hazenberg1, Arnon P Kater3,4.   

Abstract

Entities:  

Keywords:  chronic lymphocytic leukemia; innate lymphoid cells; microenvironment

Mesh：

Year:  2016        PMID： 27662009      PMCID： PMC5394863          DOI： 10.3324/haematol.2016.144725

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  IL-12 initiates tumor rejection via lymphoid tissue-inducer cells bearing the natural cytotoxicity receptor NKp46.

Authors:  Maya Eisenring; Johannes vom Berg; Glen Kristiansen; Elisabeth Saller; Burkhard Becher
Journal:  Nat Immunol       Date:  2010-10-10       Impact factor: 25.606

2.  Activated innate lymphoid cells are associated with a reduced susceptibility to graft-versus-host disease.

Authors:  J Marius Munneke; Andreas T Björklund; Jenny M Mjösberg; Karin Garming-Legert; Jochem H Bernink; Bianca Blom; Cynthia Huisman; Marinus H J van Oers; Hergen Spits; Karl-Johan Malmberg; Mette D Hazenberg
Journal:  Blood       Date:  2014-05-22       Impact factor: 22.113

Review 3.  The biology of innate lymphoid cells.

Authors:  David Artis; Hergen Spits
Journal:  Nature       Date:  2015-01-15       Impact factor: 49.962

4.  Chronic lymphocytic leukemia cells express CD38 in response to Th1 cell-derived IFN-γ by a T-bet-dependent mechanism.

Authors:  Simone Bürgler; Aleix Gimeno; Anna Parente-Ribes; Dong Wang; Audun Os; Stephen Devereux; Peter Jebsen; Bjarne Bogen; Geir E Tjønnfjord; Ludvig A Munthe
Journal:  J Immunol       Date:  2014-12-10       Impact factor: 5.422

5.  CD127+ innate lymphoid cells are dysregulated in treatment naïve acute myeloid leukemia patients at diagnosis.

Authors:  Sara Trabanelli; Antonio Curti; Mariangela Lecciso; Bérengère Salomé; Carsten Riether; Adrian Ochsenbein; Pedro Romero; Camilla Jandus
Journal:  Haematologica       Date:  2015-02-20       Impact factor: 9.941

6.  Neutralization of (NK-cell-derived) B-cell activating factor by Belimumab restores sensitivity of chronic lymphoid leukemia cells to direct and Rituximab-induced NK lysis.

Authors:  J Wild; B J Schmiedel; A Maurer; S Raab; L Prokop; S Stevanović; D Dörfel; P Schneider; H R Salih
Journal:  Leukemia       Date:  2015-02-24       Impact factor: 11.528

7.  Interleukin-23 is sufficient to induce rapid de novo gut tumorigenesis, independent of carcinogens, through activation of innate lymphoid cells.

Authors:  I H Chan; R Jain; M S Tessmer; D Gorman; R Mangadu; M Sathe; F Vives; C Moon; E Penaflor; S Turner; G Ayanoglu; C Chang; B Basham; J B Mumm; R H Pierce; J H Yearley; T K McClanahan; J H Phillips; D J Cua; E P Bowman; R A Kastelein; D LaFace
Journal:  Mucosal Immunol       Date:  2013-11-27       Impact factor: 7.313

Review 8.  Human innate lymphoid cells.

Authors:  Mette D Hazenberg; Hergen Spits
Journal:  Blood       Date:  2014-04-28       Impact factor: 22.113

Review 9.  Understanding the immunodeficiency in chronic lymphocytic leukemia: potential clinical implications.

Authors:  John C Riches; John G Gribben
Journal:  Hematol Oncol Clin North Am       Date:  2013-04       Impact factor: 3.722

10.  Expansion of NK cells and reduction of NKG2D expression in chronic lymphocytic leukemia. Correlation with progressive disease.

Authors:  Leticia Huergo-Zapico; Andrea Acebes-Huerta; Ana Pilar Gonzalez-Rodriguez; Juan Contesti; Esther Gonzalez-García; Angel R Payer; Monica Villa-Alvarez; Azahara Fernández-Guizán; Alejandro López-Soto; Segundo Gonzalez
Journal:  PLoS One       Date:  2014-10-06       Impact factor: 3.240
View more
  17 in total

1.  Changes in bone marrow innate lymphoid cell subsets in monoclonal gammopathy: target for IMiD therapy.

Authors:  Jithendra Kini Bailur; Sameet Mehta; Lin Zhang; Natalia Neparidze; Terri Parker; Noffar Bar; Tara Anderson; Mina L Xu; Kavita M Dhodapkar; Madhav V Dhodapkar
Journal:  Blood Adv       Date:  2017-11-20

Review 2.  Harnessing Unconventional T Cells and Innate Lymphoid Cells to Prevent and Treat Hematological Malignancies: Prospects for New Immunotherapy.

Authors:  Alessandro Allegra; Marco Casciaro; Elena Lo Presti; Caterina Musolino; Sebastiano Gangemi
Journal:  Biomolecules       Date:  2022-05-27

Review 3.  Innate lymphoid cells and cancer.

Authors:  Nicolas Jacquelot; Cyril Seillet; Eric Vivier; Gabrielle T Belz
Journal:  Nat Immunol       Date:  2022-02-28       Impact factor: 31.250

Review 4.  Ambiguous roles and potential therapeutic strategies of innate lymphoid cells in different types of tumor.

Authors:  Shijie Wang; Pin Wu; Yongyuan Chen; Ying Chai
Journal:  Oncol Lett       Date:  2020-06-16       Impact factor: 2.967

Review 5.  Deciphering the Roles of Innate Lymphoid Cells in Cancer.

Authors:  Melanie Bruchard; Francois Ghiringhelli
Journal:  Front Immunol       Date:  2019-04-03       Impact factor: 7.561

6.  Peripheral Innate Lymphoid Cells Are Increased in First Line Metastatic Colorectal Carcinoma Patients: A Negative Correlation With Th1 Immune Responses.

Authors:  Romain Loyon; Marine Jary; Bérengère Salomé; Alejandra Gomez-Cadena; Jeanne Galaine; Marie Kroemer; Pedro Romero; Sara Trabanelli; Olivier Adotévi; Christophe Borg; Camilla Jandus
Journal:  Front Immunol       Date:  2019-09-06       Impact factor: 7.561

Review 7.  The Interplay Between Innate Lymphoid Cells and the Tumor Microenvironment.

Authors:  Laura Ducimetière; Marijne Vermeer; Sonia Tugues
Journal:  Front Immunol       Date:  2019-12-13       Impact factor: 7.561

8.  Evaluation of immunophenotypic markers and clinico-hematological profile in chronic lymphocytic leukemia: implications for prognosis.

Authors:  Marziye Bagheri; Tina Vosoughi; Mehran Hosseinzadeh; Najmaldin Saki
Journal:  BMC Res Notes       Date:  2020-09-03

9.  Hematopoietic mosaic chromosomal alterations increase the risk for diverse types of infection.

Authors:  Seyedeh M Zekavat; Shu-Hong Lin; Alexander G Bick; Aoxing Liu; Kaavya Paruchuri; Chen Wang; Md Mesbah Uddin; Yixuan Ye; Zhaolong Yu; Xiaoxi Liu; Yoichiro Kamatani; Romit Bhattacharya; James P Pirruccello; Akhil Pampana; Po-Ru Loh; Puja Kohli; Steven A McCarroll; Krzysztof Kiryluk; Benjamin Neale; Iuliana Ionita-Laza; Eric A Engels; Derek W Brown; Jordan W Smoller; Robert Green; Elizabeth W Karlson; Matthew Lebo; Patrick T Ellinor; Scott T Weiss; Mark J Daly; Chikashi Terao; Hongyu Zhao; Benjamin L Ebert; Muredach P Reilly; Andrea Ganna; Mitchell J Machiela; Giulio Genovese; Pradeep Natarajan
Journal:  Nat Med       Date:  2021-06-07       Impact factor: 53.440

Review 10.  Helper Innate Lymphoid Cells in Allogenic Hematopoietic Stem Cell Transplantation and Graft Versus Host Disease.

Authors:  Linda Quatrini; Nicola Tumino; Francesca Moretta; Francesca Besi; Paola Vacca; Lorenzo Moretta
Journal:  Front Immunol       Date:  2020-09-30       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.